Q&A with Dr. Gerald Morris

Dr. Gerald Morris, a board-certified internist with over a decade of experience in Tucson, Arizona, transformed his regenerative medicine outcomes by adding StemWave as a pre-treatment protocol before PRP, PRF, and stem cell injections. After using the device on his own chronic knee and shoulder injuries, Dr. Morris now positions StemWave as the “Captain America” of his treatment team, reporting significantly better results and longer-lasting outcomes for patients with chronic joint and soft tissue conditions.

Who is Dr. Gerald Morris?

Dr. Gerald Morris is a practicing internist and StemWave provider based in Tucson, Arizona, with over 10 years of clinical experience in primary care medicine. His practice handles the full spectrum of internal medicine cases, including diabetes management, cholesterol issues, and chronic pain, which represents a significant portion of any primary care provider’s caseload.

Beyond traditional internal medicine, Dr. Morris has spent over five years specializing in regenerative medicine and cellular therapies. His practice offers PRP injections, PRF (platelet-rich fibrin), stem cell treatments, exosome therapy, and peptide protocols. This cellular medicine focus shapes his clinical philosophy: if you understand inflammation and cellular function, you understand the root of most disease processes.

“Inflammation is the harbinger of disease no matter what. Hands down. I don’t care what anyone tells me. This is what I know for sure,” Dr. Morris stated during the interview.

What led Dr. Morris to explore StemWave?

The regenerative medicine gap

Dr. Morris had built a successful regenerative medicine practice using PRP, PRF, and stem cell injections. Results were good. Patients improved. But something was missing.

The problem? Injecting regenerative medicine into an inflamed, dysfunctional joint is like planting seeds in toxic soil. The joint environment matters as much as what you put into it.

“Your joint is a hot mess. Literally, it’s a cesspool,” Dr. Morris explains to patients. “It has pro-inflammatory mediators. It has all the bad cytokines, all the nasty stuff that we learned in cellular medicine. It’s there.”

Putting premium regenerative medicine into that environment limits results. The “gold” of PRP or stem cells gets compromised by the inflammatory fire already burning in the joint.

Personal experience

Dr. Morris didn’t just research StemWave. Instead, he tested it on himself.

He had two chronic injuries: a meniscal knee injury lasting over three years, and a shoulder injury originating from heavy weightlifting in medical school. The shoulder would improve, then reactivate with any aggravation. A recurring cycle he’d managed for years.

“I actually put StemWave into action in my own self,” Dr. Morris shared. The personal results convinced him before he ever treated a patient.

Check out Episode #2 of our Podcast Series with Dr. Morris where he goes into full detail about inflammation, joint rehab, and the positive impact that StemWave brought to his practice.

How did Dr. Morris evaluate StemWave?

The MD skeptic’s approach

Dr. Morris acknowledges that MD’s are “heavy skeptics” by training. He didn’t accept marketing claims at face value.

“That’s what I did before I bought with you guys. I got the studies. I looked at the stuff. I say okay good, I see what the science is,” he explained.

His evaluation process:

• Reviewed published research on shockwave therapy mechanisms

• Examined how shockwave affects cellular function and inflammation

• Connected the science to his existing knowledge of cellular medicine

• Evaluated the 60-day risk-free trial as a low-risk entry point

The science connection

Dr. Morris’s background in cellular medicine made StemWave’s mechanism immediately logical. If you understand inflammation drives disease, and shockwave therapy reduces inflammation while stimulating cellular repair, the clinical application becomes obvious.

“If you understand that and understand inflammation and see what the StemWave technology does with the shockwaves and helping reducing inflammation… why not?” he concluded.

To learn more about how StemWave’s shockwave therapy separates itself from traditional radial methods, click here.

How does Dr. Morris use StemWave with regenerative medicine?

The pre-treatment protocol

Dr. Morris developed a specific integration strategy: use StemWave to prepare the joint before injecting regenerative medicine.

“What I do is a couple treatments before we actually do the cellular medicine therapy, whether it’s PRP, PRF, or whatever it is we decide to go with based on the patient’s needs,” he explained.

The protocol structure:

• Pre-treatment phase: 2-3 StemWave sessions to calm inflammation and improve joint environment

• Injection: PRP, PRF, stem cells, or exosomes based on patient needs

• Post-treatment phase: Continue remaining StemWave protocol sessions

Why pre-treatment works

Dr. Morris frames it simply for patients: don’t put gold into a cesspool.

“To put the gem that is your regenerative medicine mixture, whether it’s PRF, PRP, to put that gold in a joint that’s just on fire, you’re doing yourself a huge disservice,” he explained.

Pre-treating with StemWave:

• Calms existing inflammation

• Reduces pro-inflammatory cytokines

• Increases blood flow to the area

• Creates a receptive environment for regenerative medicine

“But prepping the joint by calming down that inflammation, calming down that fire, getting your body to increase blood flow to the area, and then putting in the good stuff, you see better bang for buck.”

Results from the combined approach

“Once I tacked on the StemWave, it just went through the roof in terms of how well people were getting better and how much longer their results were lasting,” Dr. Morris reported.

Not incremental improvement. Dramatically better outcomes. Longer-lasting results. The kind of difference that transforms clinical confidence.

What types of patients does Dr. Morris treat with StemWave?

Chronic joint conditions

As an internist seeing the full spectrum of primary care, Dr. Morris encounters chronic joint pain constantly. These patients have often tried everything: physical therapy, medications, imaging, specialist consultations.

StemWave gives him a new option before referring to pain management or orthopedic surgery.

Soft tissue injuries

Beyond joints, Dr. Morris uses StemWave for:

• Ligament strains

• Small tears in soft tissues

• Muscle injuries

• Degenerative conditions

“Using it for soft tissue injuries too, whether it’s ligament strains or even some small tears in certain other soft tissues in the joints. Game changer. And muscle too,” he noted.

Patients wanting non-surgical options

Many patients arrive at Dr. Morris’s practice specifically to avoid surgery. They want alternatives. StemWave, combined with regenerative medicine, provides that pathway.

To learn more about how StemWave can treat different types of patients, check out our behind the scenes video from a StemWave training at the Washington State Football athletic training department.

What results is Dr. Morris seeing with StemWave?

Personal outcomes

Dr. Morris experienced results firsthand with his chronic knee and shoulder injuries. After years of managing and re-aggravating these conditions, StemWave provided resolution he couldn’t achieve through other means.

Clinical outcomes

The integration with regenerative medicine protocols produced the most dramatic improvements:

• Better patient outcomes than regenerative medicine alone

• Longer-lasting results

• Faster healing trajectories

• Reduced need for repeat treatments

StemWave has been at the forefront of these clinical outcomes with its innovative technology, click here to see how StemWave has achieved a 98% success rate.

Provider validation

“I can sleep at night,” Dr. Morris shared. “I know when I leave in the evening, I did something good. I did my best to help whoever the client was. I put my best foot forward and when they’re getting better, that’s a plus.”

After over a decade in medicine, StemWave renewed his clinical satisfaction. “I’m actually upset this wasn’t around 5 years ago.”

What would Dr. Morris say to skeptical MDs?

The risk-free entry point

Dr. Morris emphasizes the 60-day trial as a game changer for skeptical physicians.

“Being able to utilize the technology for a standard like a two-month period. Test it out and if it does not fit right with your practice, give it back. I think that alone is a game changer because then I got to say why not?”

The science exists

For MDs who need research validation, it’s available.

“If you’re worried about the science, the science is out there. You read the papers. You get access,” Dr. Morris advised.

The real question

Dr. Morris poses a direct challenge to hesitant colleagues:

“The only reason you would not is if you’re not understanding the science and also if you don’t really want great patient outcomes. If you want that, I don’t see a reason why anyone would say no.”

The status quo problem

Dr. Morris calls out physician complacency directly.

“As an MD, I know my cohort. They’re not typically the go-getters. And that’s a problem because patients are suffering despite us doing what we’re doing. And we know that.”

He advocates for what he calls a “blue vase mindset”: problem-solving, searching for better solutions, refusing to accept the status quo when it stops working.

“You have to take on the lead and be like, okay, what else is there that’s out there that I can use to help get the outcomes the patients are needing?”

What makes StemWave the “Captain America” of treatment?

Dr. Morris positions StemWave as the leader of his treatment team, not a replacement for other modalities.

“It’s like the Avengers. You need Captain America to kind of lead the team, right? And that’s how I position StemWave. StemWave is the Captain America of my team because the other guys are doing great, but what I’ve noticed is adding this piece… much better for my clients.”

The adjunct philosophy

StemWave doesn’t replace regenerative medicine. It amplifies it.

“The addition of StemWave to my practice has just kind of given me a whole host of new ways to look at how you treat or a much more broader vision… to see how I can treat someone. It’s a beautiful adjunct.”

The mechanism advantage

For an MD focused on cellular medicine, StemWave’s mechanism makes scientific sense:

• Reduces inflammation at the cellular level

• Increases blood flow to treatment areas

• Activates the body’s own healing factors

• Creates optimal conditions for regenerative medicine

“The ability for the shockwave to help reduce inflammation, increase blood flow, and activate your own healing factors. That alone is reason enough.”

Check out our Q&A Webinar Session with Dr. Hendrickson to see how StemWave has become the Captain America of her practice!

Common questions about StemWave for medical doctors

How does StemWave integrate with existing regenerative medicine protocols? StemWave works as a pre-treatment to optimize joint environment before PRP, PRF, or stem cell injections. Dr. Morris recommends 2-3 StemWave sessions before injection, then completing the remaining protocol afterward. This combination produces better and longer-lasting results than regenerative medicine alone.

What’s the time commitment per treatment? StemWave treatments typically take 5-8 minutes. For busy practices, this efficiency allows integration without disrupting existing patient flow.

Can StemWave treat conditions beyond joints? Yes. Dr. Morris uses StemWave for soft tissue injuries, ligament strains, muscle injuries, and degenerative conditions throughout the body. The technology’s depth and versatility address multiple MSK conditions.

The bottom line: Dr. Morris’s StemWave integration

Dr. Gerald Morris represents a growing segment of physicians recognizing that traditional treatment models plateau for chronic conditions. Despite years of success with regenerative medicine, he found the missing piece: preparing tissues before injecting premium biologics.

StemWave didn’t replace his existing protocols. It elevated them. The “Captain America” of his treatment team now leads every regenerative medicine case, creating the optimal environment for PRP, PRF, and stem cells to work.

For MDs considering StemWave, Dr. Morris offers a simple framework:

1. The science exists. Review it.

2. The risk is minimal. Try the 60-day trial.

3. The alternative is watching patients suffer with the status quo.

“Patients are suffering despite us doing what we’re doing. And we know that,” Dr. Morris stated. “Having my eyes open and seeing that there’s other things out there that can help people and actually seeing them get helped one by one in my practice… I’m actually upset this wasn’t around 5 years ago.”

The question for providers isn’t whether StemWave works; Dr. Morris’s research, personal experience, and clinical outcomes confirms just that. The question is whether you’re ready to take the leap and lead your treatment team with a technology that amplifies everything else you do.